Blood pressure lowering efficacy of angiotensin receptor blockers for primary hypertension
about
Blood pressure lowering efficacy of beta-1 selective beta blockers for primary hypertensionBlood pressure lowering efficacy of coenzyme Q10 for primary hypertensionBlood pressure lowering efficacy of dual alpha and beta blockers for primary hypertensionBlood pressure lowering efficacy of partial agonist beta blocker monotherapy for primary hypertensionBlood pressure-lowering efficacy of loop diuretics for primary hypertensionAngiotensin converting enzyme (ACE) inhibitors versus angiotensin receptor blockers for primary hypertensionBlood pressure-lowering efficacy of monotherapy with thiazide diuretics for primary hypertensionAngiotensin receptor blockers for heart failureBlood pressure lowering efficacy of nonselective beta-blockers for primary hypertensionBlood pressure lowering efficacy of alpha blockers for primary hypertensionBlood pressure lowering efficacy of potassium-sparing diuretics (that block the epithelial sodium channel) for primary hypertensionExercise-based cardiac rehabilitation for coronary heart diseaseEffect of cyclosporine on blood pressureBlood pressure lowering efficacy of beta-blockers as second-line therapy for primary hypertensionBlood pressure lowering efficacy of diuretics as second-line therapy for primary hypertensionDifferential clinical profile of candesartan compared to other angiotensin receptor blockersDoes outcome reporting bias "cause" cancer? Risks associated with hidden data on Angiotensin receptor blockers.Hypertension management: an update.Different initiatives across Europe to enhance losartan utilization post generics: impact and implications.Use of Angiotensin receptor blockers in cardiovascular protection: current evidence and future directions.Blood pressure lowering efficacy of renin inhibitors for primary hypertension.Cost implications of improving blood pressure management among U.S. adultsModifying prescribing behaviour of angiotensin receptor blockers by selectively rescinding managerial prior authorization requirements for losartanAngiotensin receptor blockers and risk of myocardial infarction: meta-analyses and trial sequential analyses of 147 020 patients from randomised trials.Antihypertensive efficacy of angiotensin receptor blockers as monotherapy as evaluated by ambulatory blood pressure monitoring: a meta-analysis.Tolerability of Antihypertensive Medications in Older Adults.Blood pressure-lowering efficacy of reserpine for primary hypertension.Opportunities and limitations of genetic analysis of hypertensive rat strains.24-Hour blood pressure response to lower dose (30 mg) fimasartan in Korean patients with mild to moderate essential hypertension.Exercise-based cardiac rehabilitation for patients with stable anginaEfficacy and Safety of Valsartan or Chlorthalidone vs. Combined Valsartan and Chlorthalidone in Patients With Mild to Moderate Hypertension: The VACLOR Study
P2860
Q24186037-D5C5A6B8-F679-4ED5-BDC9-519DB09AE717Q24186048-E164F233-66CB-4037-8FF0-49E95659FA52Q24187752-E24800B1-A4AD-4D85-94F7-0D702A6F0834Q24187802-2DA71716-C118-4D0B-807E-5F98720B75ABQ24187853-E8C11F45-5D97-4A1E-AD99-030E62239046Q24194304-162F4767-52CD-4AE1-A6A3-6F95506A2F5BQ24194532-E4CEA453-0E38-4492-AB82-E3E6B9B832DDQ24199125-AAF2EE93-D139-4DD0-896F-84489DA39C94Q24200205-25E67165-CE23-429E-9553-E7C37F2456E9Q24201322-7E77C931-6912-4390-873A-7DD15D4D0815Q24202920-971DE7CC-14A5-4BDA-9596-562D731BD5FCQ24235365-D9BDB5CD-3D78-47E7-901E-63895D8DB8B8Q24240463-A8D2DD6E-2E27-44CC-8709-2F66B2A50AB0Q24240505-63B41A87-90BF-4045-81DF-597788A40586Q24240561-12D669F4-0FC0-42D7-B9BA-EEB9D1A484C6Q24613321-C4E907D2-5EA1-4BFA-876D-1D9CCD304B47Q30576331-58A6D577-E58C-4C91-B372-F879F6D9A400Q33932224-AFF06C6E-AE66-4268-B6B5-34B1B9163BD0Q34304782-D753D634-9BFC-47FC-83CB-00EC8254CF98Q34614447-D3792C2C-AD50-4747-A144-A306ED14EF7BQ34681386-AF116652-4860-4BF6-8869-1D2AFEDD9212Q35190993-4491F7E0-7CEE-442E-A93D-5CD312540FD6Q35629818-2B4E94DA-77C4-4C6A-B08A-0B78AF79F266Q37869264-3E1E185D-06BF-481B-91DC-BE181C4B8DBAQ38130648-20F7ECDD-58F7-45A7-839E-0AB103E8140AQ38600758-BD6E401E-304E-48BD-8BBE-6053636926E6Q39044699-B9DB61E5-741A-401C-BBD8-A6EA421247BBQ42571400-D56E9788-77C8-499E-95F1-EB10A9F7510CQ47430437-25B395A3-12E6-489B-811B-7ECB93774522Q57914770-28D3B89D-84FA-4246-B088-80D3257E2C79Q58768843-E0011989-B00F-4C8D-82DF-6CE276F3A36E
P2860
Blood pressure lowering efficacy of angiotensin receptor blockers for primary hypertension
description
2008 nî lūn-bûn
@nan
2008 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Blood pressure lowering effica ...... ckers for primary hypertension
@ast
Blood pressure lowering effica ...... ckers for primary hypertension
@en
Blood pressure lowering effica ...... ckers for primary hypertension
@en-gb
Blood pressure lowering effica ...... ckers for primary hypertension
@nl
type
label
Blood pressure lowering effica ...... ckers for primary hypertension
@ast
Blood pressure lowering effica ...... ckers for primary hypertension
@en
Blood pressure lowering effica ...... ckers for primary hypertension
@en-gb
Blood pressure lowering effica ...... ckers for primary hypertension
@nl
prefLabel
Blood pressure lowering effica ...... ckers for primary hypertension
@ast
Blood pressure lowering effica ...... ckers for primary hypertension
@en
Blood pressure lowering effica ...... ckers for primary hypertension
@en-gb
Blood pressure lowering effica ...... ckers for primary hypertension
@nl
P2093
P2860
P1476
Blood pressure lowering effica ...... ckers for primary hypertension
@en
P2093
Balraj S Heran
Inderjit K Heran
James M Wright
Michelle M Y Wong
P2860
P304
P356
10.1002/14651858.CD003822.PUB2
P577
2008-10-08T00:00:00Z